Skip to main content

ALBANY MOLECULAR Value Stock - Dividend - Research Selection

Albany molecular

ISIN: US0124231095 , WKN: 918849

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Albany Molecular Research, Inc. is a global contract research and production company. The company provides services in drug discovery, development and manufacturing. The Company operates in three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing (DPM). The DDS segment includes activities such as drug discovery, optimization, drug development, and small scale commercial production. The API covers the pilot production of active pharmaceutical ingredients and intermediates as well as the production of highly effective and controlled substances on an industrial scale. DPM encompasses preformulation, formulation, and process development by the production of complex liquid and lyophilized injectable formulations on a commercial scale. It offers a range of services and technologies that support the discovery and development of pharmaceuticals, the manufacture of drugs and medicines for new and generic medicines.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,